Schrodinger Inc(SDGR) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:33 PM ET (Korea 9/12 08:33)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.74 | Insider Own | 15.39% | Shs Outstand | 65.6M | Perf Week | -8.16% |
| Market Cap | 1.42B | Forward P/E | - | EPS next Y | 11.6% | Insider Trans | -0.76% | Shs Float | 63.3M | Perf Month | 2.09% |
| Enterprise Value | 1.11B | PEG | - | EPS next Q | -0.7 | Inst Own | 84.3% | Short Float | 17.52% | Perf Quarter | 30.27% |
| Income | -0.05B | P/S | 5.49 | EPS this Y | -13.66% | Inst Trans | -0.52% | Short Ratio | 9.58 | Perf Half Y | 56.41% |
| Sales | 0.26B | P/B | 4.32 | EPS next 5Y | 13.73% | ROA | -8.18% | Short Interest | 11.09M | Perf YTD | 6.38% |
| Book/sh | 4.4 | P/C | 3.4 | EPS past 3/5Y | 12.46% -28.1% | ROE | -16.18% | 52W High | -17.38% ($23.02) | Perf Year | 1.28% |
| Cash/sh | 5.6 | P/FCF | - | Sales past 3/5Y | 12.24% 18.81% | ROIC | -12.92% | 52W Low | 73.78% ($10.94) | Perf 3Y | -44.04% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 70.36% | Gross Margin | 56.87% | Volatility(W/M) | 4.18% 4.81% | Perf 5Y | -69.69% |
| Dividend TTM | - | EV/Sales | 4.29 | Sales Y/Y TTM | 8.88% | Oper. Margin | -59.24% | ATR (14) | 0.9 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.71 | EPS Q/Q | 113.42% | Profit Margin | -20.98% | RSI (14) | 50.85 | Recom | 1.57 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.71 | Sales Q/Q | 7.54% | SMA20 | -2.26% ($19.46) | Beta | 1.7 | Target Price | $21.43 |
| Payout | - | Debt/Eq | 0.33 | Earnings | 2026/8/5 | SMA50 | 8.33% ($17.56) | Rel Volume | 0.4 | Prev Close | $18.8 |
| Employees | 850 | LT Debt/Eq | 0.28 | EPS/Sales Surpr. | 119.3% 24.8% | SMA200 | 25.51% ($15.15) | Avg Volume(3M) | 1.16M | Price | $19.02 |
| IPO | 2020/2/6 | Option/Short | Yes/Yes | Trades | 7313 | Volume | 464,149 | Change | 1.17% |
Company
SDGR is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🧬 Schrödinger (SDGR) is a US computational sciences company that designs novel drug and new-material molecules through its physics-based computing platform. Built on long-accumulated R&D, the company licenses its software to pharmaceutical, biotech, and industrial firms as well as academic institutions, while simultaneously running its own and partnered drug discovery pipelines — a dual business model.
Over the past 1 year, roughly in the middle
17% below its 1-year high.
SDGR has weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -13.7% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -44.0% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership is about average
Institutions hold 84.3%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
LRNZ 0.03%
ARKG 0.02%
HEAL 0.01%
XDAT 0.00%
PSCH 0.00%It ranks #4 in the industry
Based on market cap of $1B.
SDGR $1B PER -
VEEV $42B PER 43.2
BTSG $12B PER 43.9
TEM $11B PER -
FAQ
What kind of company is SDGR?
SDGR belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of SDGR?
The market cap of SDGR is approximately $1.4B, ranking 2,373 within its sector.
What is the 52-week high and low for SDGR?
SDGR has recorded a 52-week high of $23.02 and a low of $10.94.
